$ACT Headlines Pfizer's plan to relocate after
Post# of 94145
Posted On: 05/13/2014 10:29:12 AM
$ACT Headlines
Pfizer's plan to relocate after merger deal draws lawmakers' fire 11:30 a.m. May 9, 2014 - blogs.marketwatch.com
Corner drug store may move overseas to save on taxes 6:30 a.m. April 16, 2014 - Al Lewis
Intuitive Surgical slumps; Facebook extends rally 3:41 p.m. April 9, 2014 - Saumya Vaishampayan
Actavis acquires Silom Medical for $100 million 10:19 a.m. April 1, 2014 - MarketWatch.com
The 10 most overbought stocks in the S&P 500 index 12:19 p.m. March 25, 2014 - The Trading Deck
UK drug rejection, patent concerns take a bite out of Celgene shares 1:33 p.m. March 14, 2014 - blogs.marketwatch.com
Mylan to start selling generic Celebrex in May 7:22 a.m. March 13, 2014 - MarketWatch.com
Pfizer loses Celebrex patent ruling; shares halted but effect muted 3:21 p.m. March 12, 2014 - blogs.marketwatch.com
Staples awash in red; eBay up as Icahn posts new letter 4:09 p.m. March 6, 2014 - Victor Reklaitis
Icahn Enterprises reports profit up 144% in 2013 10:22 a.m. March 3, 2014 - MarketWatch
Citadel hedge fund’s recent moves 11:12 a.m. Feb. 25, 2014 - Insider Monkey
Stocks rally; S&P 500 ends right below record 4:45 p.m. Feb. 24, 2014 - Victor Reklaitis
U.S. stock market is starting to ride a tech M&A wave 5:31 a.m. Feb. 24, 2014 - Wallace Witkowski
Actavis continues hot streak with better-than-expected earnings 11:21 a.m. Feb. 20, 2014 - blogs.marketwatch.com
Actavis swings to loss on charges, write-downs 8:03 a.m. Feb. 20, 2014 - MarketWatch.com
Pharma megamergers bring higher profits, better returns, study says 1:59 p.m. Feb. 19, 2014 - blogs.marketwatch.com
Actavis, Forest shares continue their climb in aftermath of $25 billion deal 11:03 a.m. Feb. 19, 2014 - blogs.marketwatch.com
U.S. stocks edge up; Nasdaq gains for 8th day in a row 4:38 p.m. Feb. 18, 2014 - Anora Mahmudova
Forest Laboratories, Actavis surge on buyout deal 4:10 p.m. Feb. 18, 2014 - Ben Eisen
S&P 500, Nasdaq extend win streaks but Dow dips: stock market live blog recap 4:06 p.m. Feb. 18, 2014 - blogs.marketwatch.com
Cross-Border Megamergers Drive Global Takeover Boom 4:01 p.m. May 12, 2014 - Investors Business Daily
3 Drugs Stocks On The Rise 1:02 p.m. May 12, 2014 - TheStreet.com
Actavis and Valeant settle patent fight 8:26 a.m. May 12, 2014 - Seeking Alpha
The 'Inversion' Premium 7:29 p.m. May 11, 2014 - The Wall Street Journal Interactive Edition
Vivus Discloses Competitive Threat 10:51 a.m. May 10, 2014 - Seeking Alpha
M.D. Sass: Bullish on Broadcast, Health Care 3:26 a.m. May 10, 2014 - Barrons.com
Acorda Misses on Earnings, Beats Revs - Analyst Blog 1:43 p.m. May 7, 2014 - Zacks.com
3 Drugs Stocks Dragging The Industry Down 1:03 p.m. May 7, 2014 - TheStreet.com
What Does Celgene's May 15 Markman Hearing Mean to You? 10:11 a.m. May 7, 2014 - TheStreet.com
Actavis, Michael Kors Among World Stocks Near Buy Points 5:50 p.m. May 6, 2014 - Investors Business Daily
10-Q: ACTAVIS PLC 5:15 p.m. May 5, 2014 - Edgar Online - (EDG = 10Q, 10K)
Hottest Healthcare Stocks Now – HMSY ACAD ACT MWIV 1:45 p.m. May 5, 2014 - InvestorPlace.com
Best Five Stocks Over $100 10:07 a.m. May 3, 2014 - 247WallSt.com
AstraZeneca Nixes New Bid As Pfizer Woos British PM 1:11 p.m. May 2, 2014 - Investors Business Daily
Earnings Beat at Endo, Shares Up on Improved Outlook - Analyst Blog 12:10 p.m. May 2, 2014 - Zacks.com
Tyco Eyes 'Business Friendly' Ireland 8:35 a.m. May 2, 2014 - The Wall Street Journal Interactive Edition
What's With All The Healthcare And Pharmaceutical Mergers? 5:25 p.m. May 1, 2014 - TheStreet.com
Avanir Wins Lawsuit, Shares Up - Analyst Blog 4:39 p.m. May 1, 2014 - Zacks.com
A Look At World Stocks' Q1: Shire, Actavis, NXP Semi 4:32 p.m. May 1, 2014 - Investors Business Daily
Mylan Beats on Earnings, Misses on Sales - Analyst Blog 1:17 p.m. May 1, 2014 - Zacks.com
Actavis Announces Acanya® Gel Patent Challenge Settlement 8:00 a.m. May 12, 2014 - PR Newswire - PRF
Technical Coverage on Pharma Equities -- Research on Allergan, Actavis, Medicines Co., and Akorn 11:30 a.m. May 9, 2014 - PR Newswire - PRF
Actavis Launches Generic Version of Catapres-TTS® 4:05 p.m. May 7, 2014 - PR Newswire - PRF
Financial Results, Study Results, and Conference Schedules - Analyst Notes on Actavis, BMS, Baxter, Biogen Idec and AbbVie 9:00 a.m. May 6, 2014 - PR Newswire - PRF
Actavis and Forest Announce Effectiveness of Registration Statement on Form S-4 9:02 a.m. May 5, 2014 - BusinessWire - BZX
Actavis and Forest Announce Effectiveness of Registration Statement on Form S-4 9:00 a.m. May 5, 2014 - PR Newswire - PRF
Pfizer Expects $100 Billion Grab for AstraZeneca to Boost Pipeline and Drop Tax Rate, an Industrial Info News Alert 6:31 a.m. April 30, 2014 - Marketwire
Stocks Close to Reporting their Earnings -- Research on Actavis, NYSE Community Bancorp, Hess, and Dominion Resources 4:36 a.m. April 30, 2014 - PR Newswire - PRF
Actavis Sues FDA Regarding Delay of Generic Celebrex® Approval 5:14 p.m. April 28, 2014 - PR Newswire - PRF
Strategic Collaborations, Fresh Agreements, and Upcoming Conferences - Analyst Notes on Biogen, Bristol-Myers, AbbVie, Actavis and Bard 8:00 a.m. April 28, 2014 - PR Newswire - PRF
Stockholder Rights Plan, Quarterly Results, Clinical Trial Results, Purchase Agreements, and New Contracts - Analyst Notes on Allergan, Gilead, Pfizer, Actavis and Express Scripts 8:00 a.m. April 25, 2014 - PR Newswire - PRF
Actavis Announces Celebrex® Patent Challenge Settlement 9:20 a.m. April 24, 2014 - PR Newswire - PRF
Actavis Announces Departure of G. Frederick Wilkinson, President, Actavis Global R&D 9:03 a.m. April 21, 2014 - PR Newswire - PRF
Actavis to Acquire Four Products from Akorn 4:15 p.m. April 17, 2014 - PR Newswire - PRF
Actavis and Forest Laboratories Receive FTC Second Request Under Hart-Scott-Rodino 4:05 p.m. April 17, 2014 - BusinessWire - BZX
Actavis and Forest Laboratories Receive FTC Second Request Under Hart-Scott-Rodino 4:05 p.m. April 17, 2014 - PR Newswire - PRF
Actavis Announces Agreement Related to Generess® FE Patent Challenge Litigation 8:00 a.m. April 15, 2014 - PR Newswire - PRF
Recent Acquisitions, Trial Opinions, Upcoming Earnings, Inducement Grants, and Clinical Trial Results - Analyst Notes on Actavis, The Medicines Company, Hospira, Horizon Pharma, and Galectin 8:00 a.m. April 11, 2014 - PR Newswire - PRF
Pharma Equities under Review -- Research on Mylan, Actavis, Hospira, and Medicines 12:30 p.m. April 10, 2014 - PR Newswire - PRF
Actavis Launches Asia Pacific Regional Headquarters in Singapore 8:00 p.m. April 2, 2014 - PR Newswire - PRF
Pfizer's plan to relocate after merger deal draws lawmakers' fire 11:30 a.m. May 9, 2014 - blogs.marketwatch.com
Corner drug store may move overseas to save on taxes 6:30 a.m. April 16, 2014 - Al Lewis
Intuitive Surgical slumps; Facebook extends rally 3:41 p.m. April 9, 2014 - Saumya Vaishampayan
Actavis acquires Silom Medical for $100 million 10:19 a.m. April 1, 2014 - MarketWatch.com
The 10 most overbought stocks in the S&P 500 index 12:19 p.m. March 25, 2014 - The Trading Deck
UK drug rejection, patent concerns take a bite out of Celgene shares 1:33 p.m. March 14, 2014 - blogs.marketwatch.com
Mylan to start selling generic Celebrex in May 7:22 a.m. March 13, 2014 - MarketWatch.com
Pfizer loses Celebrex patent ruling; shares halted but effect muted 3:21 p.m. March 12, 2014 - blogs.marketwatch.com
Staples awash in red; eBay up as Icahn posts new letter 4:09 p.m. March 6, 2014 - Victor Reklaitis
Icahn Enterprises reports profit up 144% in 2013 10:22 a.m. March 3, 2014 - MarketWatch
Citadel hedge fund’s recent moves 11:12 a.m. Feb. 25, 2014 - Insider Monkey
Stocks rally; S&P 500 ends right below record 4:45 p.m. Feb. 24, 2014 - Victor Reklaitis
U.S. stock market is starting to ride a tech M&A wave 5:31 a.m. Feb. 24, 2014 - Wallace Witkowski
Actavis continues hot streak with better-than-expected earnings 11:21 a.m. Feb. 20, 2014 - blogs.marketwatch.com
Actavis swings to loss on charges, write-downs 8:03 a.m. Feb. 20, 2014 - MarketWatch.com
Pharma megamergers bring higher profits, better returns, study says 1:59 p.m. Feb. 19, 2014 - blogs.marketwatch.com
Actavis, Forest shares continue their climb in aftermath of $25 billion deal 11:03 a.m. Feb. 19, 2014 - blogs.marketwatch.com
U.S. stocks edge up; Nasdaq gains for 8th day in a row 4:38 p.m. Feb. 18, 2014 - Anora Mahmudova
Forest Laboratories, Actavis surge on buyout deal 4:10 p.m. Feb. 18, 2014 - Ben Eisen
S&P 500, Nasdaq extend win streaks but Dow dips: stock market live blog recap 4:06 p.m. Feb. 18, 2014 - blogs.marketwatch.com
Cross-Border Megamergers Drive Global Takeover Boom 4:01 p.m. May 12, 2014 - Investors Business Daily
3 Drugs Stocks On The Rise 1:02 p.m. May 12, 2014 - TheStreet.com
Actavis and Valeant settle patent fight 8:26 a.m. May 12, 2014 - Seeking Alpha
The 'Inversion' Premium 7:29 p.m. May 11, 2014 - The Wall Street Journal Interactive Edition
Vivus Discloses Competitive Threat 10:51 a.m. May 10, 2014 - Seeking Alpha
M.D. Sass: Bullish on Broadcast, Health Care 3:26 a.m. May 10, 2014 - Barrons.com
Acorda Misses on Earnings, Beats Revs - Analyst Blog 1:43 p.m. May 7, 2014 - Zacks.com
3 Drugs Stocks Dragging The Industry Down 1:03 p.m. May 7, 2014 - TheStreet.com
What Does Celgene's May 15 Markman Hearing Mean to You? 10:11 a.m. May 7, 2014 - TheStreet.com
Actavis, Michael Kors Among World Stocks Near Buy Points 5:50 p.m. May 6, 2014 - Investors Business Daily
10-Q: ACTAVIS PLC 5:15 p.m. May 5, 2014 - Edgar Online - (EDG = 10Q, 10K)
Hottest Healthcare Stocks Now – HMSY ACAD ACT MWIV 1:45 p.m. May 5, 2014 - InvestorPlace.com
Best Five Stocks Over $100 10:07 a.m. May 3, 2014 - 247WallSt.com
AstraZeneca Nixes New Bid As Pfizer Woos British PM 1:11 p.m. May 2, 2014 - Investors Business Daily
Earnings Beat at Endo, Shares Up on Improved Outlook - Analyst Blog 12:10 p.m. May 2, 2014 - Zacks.com
Tyco Eyes 'Business Friendly' Ireland 8:35 a.m. May 2, 2014 - The Wall Street Journal Interactive Edition
What's With All The Healthcare And Pharmaceutical Mergers? 5:25 p.m. May 1, 2014 - TheStreet.com
Avanir Wins Lawsuit, Shares Up - Analyst Blog 4:39 p.m. May 1, 2014 - Zacks.com
A Look At World Stocks' Q1: Shire, Actavis, NXP Semi 4:32 p.m. May 1, 2014 - Investors Business Daily
Mylan Beats on Earnings, Misses on Sales - Analyst Blog 1:17 p.m. May 1, 2014 - Zacks.com
Actavis Announces Acanya® Gel Patent Challenge Settlement 8:00 a.m. May 12, 2014 - PR Newswire - PRF
Technical Coverage on Pharma Equities -- Research on Allergan, Actavis, Medicines Co., and Akorn 11:30 a.m. May 9, 2014 - PR Newswire - PRF
Actavis Launches Generic Version of Catapres-TTS® 4:05 p.m. May 7, 2014 - PR Newswire - PRF
Financial Results, Study Results, and Conference Schedules - Analyst Notes on Actavis, BMS, Baxter, Biogen Idec and AbbVie 9:00 a.m. May 6, 2014 - PR Newswire - PRF
Actavis and Forest Announce Effectiveness of Registration Statement on Form S-4 9:02 a.m. May 5, 2014 - BusinessWire - BZX
Actavis and Forest Announce Effectiveness of Registration Statement on Form S-4 9:00 a.m. May 5, 2014 - PR Newswire - PRF
Pfizer Expects $100 Billion Grab for AstraZeneca to Boost Pipeline and Drop Tax Rate, an Industrial Info News Alert 6:31 a.m. April 30, 2014 - Marketwire
Stocks Close to Reporting their Earnings -- Research on Actavis, NYSE Community Bancorp, Hess, and Dominion Resources 4:36 a.m. April 30, 2014 - PR Newswire - PRF
Actavis Sues FDA Regarding Delay of Generic Celebrex® Approval 5:14 p.m. April 28, 2014 - PR Newswire - PRF
Strategic Collaborations, Fresh Agreements, and Upcoming Conferences - Analyst Notes on Biogen, Bristol-Myers, AbbVie, Actavis and Bard 8:00 a.m. April 28, 2014 - PR Newswire - PRF
Stockholder Rights Plan, Quarterly Results, Clinical Trial Results, Purchase Agreements, and New Contracts - Analyst Notes on Allergan, Gilead, Pfizer, Actavis and Express Scripts 8:00 a.m. April 25, 2014 - PR Newswire - PRF
Actavis Announces Celebrex® Patent Challenge Settlement 9:20 a.m. April 24, 2014 - PR Newswire - PRF
Actavis Announces Departure of G. Frederick Wilkinson, President, Actavis Global R&D 9:03 a.m. April 21, 2014 - PR Newswire - PRF
Actavis to Acquire Four Products from Akorn 4:15 p.m. April 17, 2014 - PR Newswire - PRF
Actavis and Forest Laboratories Receive FTC Second Request Under Hart-Scott-Rodino 4:05 p.m. April 17, 2014 - BusinessWire - BZX
Actavis and Forest Laboratories Receive FTC Second Request Under Hart-Scott-Rodino 4:05 p.m. April 17, 2014 - PR Newswire - PRF
Actavis Announces Agreement Related to Generess® FE Patent Challenge Litigation 8:00 a.m. April 15, 2014 - PR Newswire - PRF
Recent Acquisitions, Trial Opinions, Upcoming Earnings, Inducement Grants, and Clinical Trial Results - Analyst Notes on Actavis, The Medicines Company, Hospira, Horizon Pharma, and Galectin 8:00 a.m. April 11, 2014 - PR Newswire - PRF
Pharma Equities under Review -- Research on Mylan, Actavis, Hospira, and Medicines 12:30 p.m. April 10, 2014 - PR Newswire - PRF
Actavis Launches Asia Pacific Regional Headquarters in Singapore 8:00 p.m. April 2, 2014 - PR Newswire - PRF
(0)
(0)Scroll down for more posts ▼